29409526|t|Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.
29409526|a|BACKGROUND: Progressive neuron loss in the frontal and temporal lobes of the cerebral cortex typifies frontotemporal lobar degeneration (FTLD). FTLD sub types are classified on the basis of neuronal aggregated protein deposits, typically containing either aberrantly phosphorylated TDP-43 or tau. Our recent work demonstrated that tau tubulin kinases 1 and 2 (TTBK1/2) robustly phosphorylate TDP-43 and co-localize with phosphorylated TDP-43 in human postmortem neurons from FTLD patients. Both TTBK1 and TTBK2 were initially identified as tau kinases and TTBK1 has been shown to phosphorylate tau epitopes commonly observed in Alzheimer's disease and other tauopathies. METHODS: To further elucidate how TTBK1/2 activity contributes to both TDP-43 and tau phosphorylation in the context of the neurodegeneration seen in FTLD, we examined the consequences of elevated human TTBK1/2 kinase expression in transgenic animal models of disease. RESULTS: We show that C. elegans co-expressing tau/TTBK1 tau/TTBK2, or TDP-43/TTBK1 transgenes in combination exhibit synergistic exacerbation of behavioral abnormalities and increased pathological protein phosphorylation. We also show that C. elegans co-expressing tau/TTBK1 or tau/TTBK2 transgenes in combination exhibit aberrant neuronal architecture and neuron loss. Surprisingly, the TTBK2/TDP-43 transgenic combination showed no exacerbation of TDP-43 proteinopathy related phenotypes. Additionally, we observed elevated TTBK1/2 protein expression in cortical and hippocampal neurons of FTLD-tau and FTLD-TDP cases relative to normal controls. CONCLUSIONS: Our findings suggest a possible etiology for the two most common FTLD subtypes through a kinase activation driven mechanism of neurodegeneration.
29409526	32	35	tau	Gene	4137
29409526	40	46	TDP-43	Gene	23435
29409526	50	55	TTBK1	Gene	84630
29409526	60	65	TTBK2	Gene	146057
29409526	73	90	neurodegeneration	Disease	MESH:D019636
29409526	116	127	neuron loss	Disease	MESH:D009410
29409526	194	227	frontotemporal lobar degeneration	Disease	MESH:D057174
29409526	229	233	FTLD	Disease	MESH:D057174
29409526	236	240	FTLD	Disease	MESH:D057174
29409526	374	380	TDP-43	Gene	23435
29409526	384	387	tau	Gene	4137
29409526	423	450	tau tubulin kinases 1 and 2	Gene	84630;146057
29409526	452	459	TTBK1/2	Gene	84630;146057
29409526	484	490	TDP-43	Gene	23435
29409526	527	533	TDP-43	Gene	23435
29409526	537	542	human	Species	9606
29409526	567	571	FTLD	Disease	MESH:D057174
29409526	572	580	patients	Species	9606
29409526	587	592	TTBK1	Gene	84630
29409526	597	602	TTBK2	Gene	146057
29409526	632	635	tau	Gene	4137
29409526	648	653	TTBK1	Gene	84630
29409526	686	689	tau	Gene	4137
29409526	720	739	Alzheimer's disease	Disease	MESH:D000544
29409526	750	761	tauopathies	Disease	MESH:D024801
29409526	797	804	TTBK1/2	Gene	84630;146057
29409526	834	840	TDP-43	Gene	23435
29409526	845	848	tau	Gene	4137
29409526	887	904	neurodegeneration	Disease	MESH:D019636
29409526	913	917	FTLD	Disease	MESH:D057174
29409526	960	965	human	Species	9606
29409526	966	973	TTBK1/2	Gene	84630;146057
29409526	1054	1064	C. elegans	Species	328850
29409526	1079	1082	tau	Gene	4137
29409526	1083	1088	TTBK1	Gene	84630
29409526	1089	1092	tau	Gene	4137
29409526	1093	1098	TTBK2	Gene	146057
29409526	1103	1109	TDP-43	Gene	23435
29409526	1110	1115	TTBK1	Gene	84630
29409526	1178	1202	behavioral abnormalities	Disease	MESH:D001523
29409526	1273	1283	C. elegans	Species	328850
29409526	1298	1301	tau	Gene	4137
29409526	1302	1307	TTBK1	Gene	84630
29409526	1311	1314	tau	Gene	4137
29409526	1315	1320	TTBK2	Gene	146057
29409526	1390	1401	neuron loss	Disease	MESH:D009410
29409526	1421	1426	TTBK2	Gene	146057
29409526	1427	1433	TDP-43	Gene	23435
29409526	1483	1503	TDP-43 proteinopathy	Disease	MESH:D057177
29409526	1559	1566	TTBK1/2	Gene	84630;146057
29409526	1625	1630	FTLD-	Disease	MESH:D057174
29409526	1630	1633	tau	Gene	4137
29409526	1638	1646	FTLD-TDP	Disease	MESH:D057174
29409526	1760	1764	FTLD	Disease	MESH:D057174
29409526	1822	1839	neurodegeneration	Disease	MESH:D019636
29409526	Association	146057	4137
29409526	Association	MESH:D000544	4137
29409526	Association	MESH:D009410	4137
29409526	Positive_Correlation	MESH:D009410	146057
29409526	Association	MESH:D019636	23435
29409526	Association	MESH:D019636	146057
29409526	Association	4137	84630
29409526	Association	23435	84630
29409526	Association	MESH:D024801	84630
29409526	Association	MESH:D057174	84630
29409526	Association	MESH:D000544	84630
29409526	Positive_Correlation	MESH:D001523	23435
29409526	Association	MESH:D057174	23435
29409526	Association	MESH:D019636	84630
29409526	Association	MESH:D057174	4137
29409526	Association	MESH:D057174	146057
29409526	Association	MESH:D024801	4137
29409526	Association	MESH:D019636	4137
29409526	Positive_Correlation	MESH:D001523	84630
29409526	Positive_Correlation	MESH:D001523	4137
29409526	Association	146057	23435
29409526	Association	MESH:D001523	146057

